Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/29273
Title: Expansion of a 12-kb VNTR containing the REXO1L1 gene cluster underlies the microscopically visible euchromatic variant of 8q21.2
Authors: Tyson, Christine
Hrynchak, Monica
Sharp, Andrew J .
Warburton, Peter
Yong, Siu Li
Hollox, Edward J
Barber, John C. K.
First Published: 18-Sep-2013
Publisher: Nature Publishing Group for European Society of Human Genetics
Citation: European Journal of Human Genetics, 2014, 22 (4), pp. 458-463
Abstract: Copy number variants visible with the light microscope have been described as euchromatic variants (EVs) and EVs with extra G-light material at 8q21.2 have been reported only once before. We report four further patients with EVs of 8q21.2 ascertained for clinical (3) or reproductive reasons (1). Enhanced signal strength from two overlapping bacterial artificial chromosomes (BACs) and microarray analysis mapped the EV to a 284-kb interval in the reference genome. This interval consists of a sequence gap flanked by segmental duplications that contain the 12-kb components of one of the largest Variable Number Tandem Repeat arrays in the human genome. Using digital NanoString technology with a custom probe for the RNA exonuclease 1 homologue (S. cerevisiae)-like 1 (REXO1L1) gene within each 12-kb repeat, significantly enhanced diploid copy numbers of 270 and 265 were found in an EV family and a median diploid copy number of 166 copies in 216 controls. These 8q21.2 EVs are not thought to have clinical consequences as the phenotypes of the probands were inconsistent, those referred for reproductive reasons were otherwise phenotypically normal and the REXO1L1 gene has no known disease association. This EV was found in 4/3078 (1 in 770) consecutive referrals for chromosome analysis and needs to be distinguished from pathogenic imbalances of medial 8q. The REXO1L1 gene product is a marker of hepatitis C virus (HCV) infection and a possible association between REXO1L1 copy number and susceptibility to HCV infection, progression or response to treatment has not yet been excluded.
DOI Link: 10.1038/ejhg.2013.185
ISSN: 1018-4813
eISSN: 1476-5438
Links: http://www.nature.com/ejhg/journal/v22/n4/full/ejhg2013185a.html
http://hdl.handle.net/2381/29273
Version: Post-print
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © 2013,Nature Publishing Group for European Society of Human Genetics. Deposited with reference to the publisher’s archiving policy available on the SHERPA/RoMEO website.
Appears in Collections:Published Articles, Dept. of Genetics

Files in This Item:
File Description SizeFormat 
088-13 EJHGR, Tyson et al, 8q21.2 CNV as re-submitted, 25-05-2013.pdfPost-review (final submitted)602.94 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.